4
Changes in Ownership
PHIBRO ANIMAL HEALTH CORP Filed Acc 0001144204-18-034115
President and CEO sold 30,000 shares at an average $46.44 ($1,393,200)
- President and CEO acquired 32,530 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK President and CEO | 2018-06-11 | Sale | −10,000 | $46.46 | $464,600 | 17,470 | I: show line 1 in the form |
| BENDHEIM JACK President and CEO | 2018-06-12 | Conversion | +32,530 | 50,000 | I: show line 2 in the form | ||
| BENDHEIM JACK President and CEO | 2018-06-12 | Sale | −10,000 | $46.26 | $462,600 | 40,000 | I: show line 3 in the form |
| BENDHEIM JACK President and CEO | 2018-06-13 | Sale | −10,000 | $46.60 | $466,000 | 30,000 | I: show line 4 in the form |
| Open-market sales · 30,000 sh · avg $46.44 · $1,393,200 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BENDHEIM JACK President and CEO | 2018-06-12 | Conversion · Class B Common Stock | −32,530 | 20,425,504 | D: show line 5 in the form |
Loading xslF345X03/tv496295_form4.xml…